Amidst rising costs across all areas of our business, and aggressive attempts to implement cost savings without sacrificing quality, we announce the need to implement a cost increase starting July 1, 2022. If you have questions, please contact your sales representative.
Inhibitors |
|
Cat. No. | Product Name / Activity |
---|---|
5213 | LL 37 |
Inhibitor of SARS-CoV-2 S1 spike protein and ACE2 interaction | |
Substrates |
|
Cat. No. | Product Name / Activity |
1563 | Angiotensin I (human, mouse, rat) |
Potent endogenous vasoconstrictor peptide; substrate for ACE and ACE2 | |
1158 | Angiotensin II |
Potent endogenous vasoconstrictor peptide; substrate for ACE2 | |
Other |
|
Cat. No. | Product Name / Activity |
7233 | SBP1 |
ACE2 derived peptide; binds SARS-CoV-2 spike protein receptor binding domain | |
7322 | SP 10 |
Highly potent inhibitor of SARS-CoV Spike (S) protein and ACE2 interaction |